| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/08/2011 | US20110217292 Monoclonal antibodies against hmgb1 |
| 09/08/2011 | US20110217290 Treatment and/or prevention of peanut induced anaphylaxis |
| 09/08/2011 | US20110217279 Use of human biliverdin reductase and fragments thereof for the treatment of protein kinase c-delta and erk related conditions |
| 09/08/2011 | US20110217244 Compositions and methods for enhancing immune response |
| 09/08/2011 | US20110217232 Method for Determination of the Responsiveness of an Individual to Misletoe Lectin |
| 09/08/2011 | DE102010010288A1 Medicament, useful to prevent or treat e.g. ulcerative colitis, comprises polypeptide sequences of cysteine-rich protein 61 (CCN1) and/or cyclic arginine-glycine-aspartic acid peptide, or nucleic acid encoding polypeptide sequence of CCN1 |
| 09/07/2011 | EP2363493A1 Novel insertion sites in pox vectors |
| 09/07/2011 | EP2363487A2 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
| 09/07/2011 | EP2363468A1 Tumor antigen peptide and use thereof |
| 09/07/2011 | EP2363404A2 PSMA antibodies |
| 09/07/2011 | EP2363149A1 Combinations comprising a S1P receptor agonist and a JAK3 kinase inhibitor |
| 09/07/2011 | EP2363139A1 Method to increase class I presentation of exogenous antigens by human dendritic cells |
| 09/07/2011 | EP2363138A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring periodontal diseases |
| 09/07/2011 | EP2363133A1 Composition comprising DNA fragments and medical and cosmetic uses thereof |
| 09/07/2011 | EP2363120A1 Combinations of dimebolin and memantine |
| 09/07/2011 | EP2362866A1 Isoprenyl compounds and methods thereof |
| 09/07/2011 | EP2362773A1 Methods for inducing programmed cell death |
| 09/07/2011 | EP2362771A1 Combinational therapy comprising dhodh inhibitor and methotrexate for treating autoimmune disease |
| 09/07/2011 | CN102177178A Anti-IL-12/IL-23 antibodies |
| 09/07/2011 | CN102177159A Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 09/07/2011 | CN102177144A Crystalline forms of (R) -5- [3-chloro-4- ( 2, 3-dihydroxy-propoxy) -benz [Z] ylidene] -2- ( [Z] -propylimino) -3-0-tolyl-thiazolidin-4-one |
| 09/07/2011 | CN102176913A Tacrolimus preparation for external applications |
| 09/07/2011 | CN102176907A Oral vaccines for producing mucosal immunity |
| 09/07/2011 | CN102175786A Aminopropanol derivatives |
| 09/07/2011 | CN102174628A Preparation method of peanut bioactive peptides |
| 09/07/2011 | CN102174615A Method for producing fungal polysaccharide with residues after extraction of polysaccharide using needle mushroom |
| 09/07/2011 | CN102174614A Antarctic cold-adapted microbial extracellular polysaccharide capable of improving body immunity |
| 09/07/2011 | CN102174515A Promoter for introducing gene into lymphocyte or blood cell and application thereof |
| 09/07/2011 | CN102174414A Application of new morchella costata M8-13 liquid fermentation substance to development of health-care products and medicaments |
| 09/07/2011 | CN102174119A Selenized carrageenan and preparation method thereof |
| 09/07/2011 | CN102174111A Human interleukin-2 (IL-2)/Fc fusion protein |
| 09/07/2011 | CN102174108A Internalizing anti-cd74 antibodies and methods of use |
| 09/07/2011 | CN102174084A Cyclic peptide analogues with thymosin alpha1 activity fragments and polyethylene glycol derivatives thereof |
| 09/07/2011 | CN102174083A Compositae cyclopeptide, immunosuppressive medicine using compositae cyclopeptide as active ingredient and preparation method and application of compositae cyclopeptide |
| 09/07/2011 | CN102174076A Compounds for proteasome enzyme inhibition |
| 09/07/2011 | CN102174074A Inhabitors of cancer cell, T-cell and keratinocyte proliferation |
| 09/07/2011 | CN102174073A Oyster protein peptide and zinc chelate and method for preparing same |
| 09/07/2011 | CN102174046A Tetomilast polymorphs |
| 09/07/2011 | CN102174045A Tetomilast polymorphs |
| 09/07/2011 | CN102174044A Tetomilast polymorphs |
| 09/07/2011 | CN102174042A Immunosuppressant compounds and compositions |
| 09/07/2011 | CN102174024A 2,4-pyrimidinediamine compounds and their uses |
| 09/07/2011 | CN102172403A Method for treating interleukin-6 related diseases |
| 09/07/2011 | CN102172397A In vivo targeting of dendritic cells |
| 09/07/2011 | CN102172393A Calcium supplement of fish scale protein peptide calcium chelate and preparation method thereof |
| 09/07/2011 | CN102172385A Chinese medicinal preparation with effects of enhancing immunity, lowering blood sugar and lowering blood fat |
| 09/07/2011 | CN102172384A Chinese medicinal preparation with effects of resisting fatigue and enhancing immunity |
| 09/07/2011 | CN102172383A Chinese medicinal preparation having functions of enhancing immunity, promoting digestion and improving sleep |
| 09/07/2011 | CN102172358A Timicosin compound preparation and preparation method and use thereof |
| 09/07/2011 | CN102172357A Core 2 glcnac-t inhibitors |
| 09/07/2011 | CN101926826B Method for extracting active ingredients from sea horse |
| 09/07/2011 | CN101912513B Traditional Chinese medicinal preparation for treating eczema |
| 09/07/2011 | CN101816693B Echinacea purpurea extract powder and preparation method and application thereof |
| 09/07/2011 | CN101632795B Linnaeus penis capsules and preparation method thereof |
| 09/07/2011 | CN101629182B Eukaryotic expression plasmid of chicken defensin-1 gene and molecular adjuvants prepared by the gene and vaccine |
| 09/07/2011 | CN101597337B Conjugate of hydroxyalkyl starch and an active agent |
| 09/07/2011 | CN101469016B Trichosanthin protein derived peptide and use thereof |
| 09/07/2011 | CN101417105B Zedoary turmeric oil glucose injection and preparation method thereof |
| 09/07/2011 | CN101380461B Efficient thymosin enteric-coated tablets and thymosin for injection |
| 09/07/2011 | CN101230103B Human recombinant anti-IgE antibody |
| 09/07/2011 | CN101163716B Interleukin-6 polyethylene glycol conjugate and its preparing method and use |
| 09/07/2011 | CN101156936B An administer orally mixed nucleus glycosides as well as its preparing technics |
| 09/07/2011 | CN101151020B Adjuvanting material |
| 09/06/2011 | US8013124 for stimulating the immune system, and proliferation and/or development of hematopoietic cells; production of proinflammatory cytokines |
| 09/06/2011 | US8012997 Isoindole-imide compounds, compositions, and uses thereof |
| 09/06/2011 | US8012996 Methods and composition for inhibition of angiogenesis |
| 09/06/2011 | US8012995 Pharmaceutically active sulfonamide derivatives |
| 09/06/2011 | US8012964 9-substituted 8-oxoadenine compound |
| 09/06/2011 | US8012934 Small peptides and methods for treatment of inflammation |
| 09/06/2011 | US8012754 Antibody compositions |
| 09/06/2011 | US8012476 Molecules with extended half-lives, compositions and uses thereof |
| 09/06/2011 | US8012469 Universal GM-CSF expressing bystander human K562 cell line |
| 09/06/2011 | CA2559633C Vaccine compositions obtained from streptomyces |
| 09/06/2011 | CA2493785C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/06/2011 | CA2465746C Hydrazono-malonitriles |
| 09/06/2011 | CA2449419C Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
| 09/06/2011 | CA2396148C Improved pediatric formula and methods for providing nutrition and improving tolerance |
| 09/06/2011 | CA2373360C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 09/06/2011 | CA2336361C Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same |
| 09/01/2011 | WO2011106723A2 Anti-paf antibodies |
| 09/01/2011 | WO2011106168A1 Purine compounds for treating autoimmune and demyelinating diseases |
| 09/01/2011 | WO2011105394A1 Method for producing regulatory dendritic cells |
| 09/01/2011 | WO2011104687A1 Antagonist anti-il-7 receptor antibodies and methods |
| 09/01/2011 | WO2011104214A1 Silicon-containing biodegradable material for anti-inflammatory therapy |
| 09/01/2011 | WO2011103771A1 Sterilized natural antigen mixture for prevention and treatment of allergy |
| 09/01/2011 | WO2011103701A1 Full human anti-tnf- alpha monoclonal antibody, preparation method and use thereof |
| 09/01/2011 | WO2011103666A1 Modulation of cytokine-induced chronic inflammatory responses |
| 09/01/2011 | US20110214194 Compositions and methods for modulating cells via cd14 and toll-like receptor 4 signaling pathway |
| 09/01/2011 | US20110213337 Methods for the early diagnosis of ovarian cancer |
| 09/01/2011 | US20110213236 Therapeutic compositions, devices and methods for observing treated tissues |
| 09/01/2011 | US20110213029 3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands |
| 09/01/2011 | US20110213028 Fatty acid mycophenolate derivatives and their uses |
| 09/01/2011 | US20110213020 Immunostimulant compositions comprising a nucleobase and a polysaccharide obtainable from fungi, yeast or bacteria |
| 09/01/2011 | US20110213014 Compositions and methods for topical delivery of oligonucleotides |
| 09/01/2011 | US20110213002 Macrocyclic diterpenes for treating conditions associated with protein kinase c |
| 09/01/2011 | US20110212998 Pyridine derivatives as s1p1/edg1 receptor modulators |
| 09/01/2011 | US20110212988 Tacrolimus preparation for external applications |
| 09/01/2011 | US20110212970 Compounds that modulate intracellular calcium |
| 09/01/2011 | US20110212940 S1P Receptor Modulating Compounds and Use Thereof |
| 09/01/2011 | US20110212935 Compositions and treatment methods-4 |